IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#3215
Positioning
Market Dominance
Services
Healthcare
$63M
N/A
N/A
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = ATPC ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$ATPC Agape ATP Corp | 42 | 26 | 24 | 47 | - | - | -10.8% | -10.1% | 54.8% | -178.4% | -174.8% | 18.4% | 0.0% | 7.0x | $63M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
Agape ATP Corp (ATPC) receives a "Reduce" rating with a composite score of 42.4/100. It ranks #3215 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
In-line with peers — no strong momentum signal
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for ATPC.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 26 | 11 | +15ALPHA |
| MOMENTUM | 47 | 46 | +1NEUTRAL |
| VALUATION | 24 | 15 | +9ALPHA |
| INVESTMENT | 21 | 5 | +16ALPHA |
| STABILITY | 25 | 16 | +9ALPHA |
| SHORT INT | 88 | 97 | -9DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -10.8% (sector 5.7%)
GM 55% vs sector 65%, OM -178% vs sector 5%
Capital turnover N/A
Rev growth 18%, 8yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Agape ATP Corp (ATPC) as a Reduce with a composite score of 42.4/100 at a current price of $1.96. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential.
Agape ATP Corp holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 42.4/100 places it at rank #3215 in our full universe.
No Moat
High
Poor
Fair Value
Gross margins of 55% signal strong pricing power.
Stable competitive position in a defensive sector.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
Agape ATP Corp represents a reduce based on multi-factor quantitative performance.
Agape ATP Corp receives a Reduce rating from our analysis, with a composite score of 42.4/100 and 2 out of 5 stars, ranking #3215 out of 7,333 stocks. ATPC's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
ATPC's quality score of 26/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -10.8% (sector avg: 5.7%), gross margins of 54.8% (sector avg: 64.6%), net margins of -174.8% (sector avg: 2.8%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
ATPC registers a value score of just 24/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.09x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Agape ATP Corp's investment score of 21/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 18.4% vs. a sector average of 8.6% and a return on assets of -10.1% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
ATPC is currently showing below-average momentum at 47/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 18.4% year-over-year, while a beta of -4.91 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
ATPC's stability score of 25/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -4.91 and a debt-to-equity ratio of 7.00x (sector avg: 0.3x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
ATPC's short interest factor score of 88/100 indicates very low short selling activity relative to peers — a positive signal suggesting institutional investors see limited near-term downside. Specific risk factors include elevated leverage (D/E: 7.00x), micro-cap liquidity risk. As a micro-cap company with a market capitalization of $63M, Agape ATP Corp benefits from the generally lower volatility and deeper liquidity associated with its size class.
Agape ATP Corp is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #3215 of 7,333 overall (56th percentile). Key comparisons include ROE of -10.8% trailing the 5.7% sector median and operating margins of -178.4% below the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While ATPC currently exhibits a REDUCE profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Investment (21) would have the largest impact on the composite score.
ROE 288% BELOW SECTOR MEDIAN
Gross Margin 15% BELOW SECTOR MEDIAN
Op. Margin 4065% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales guidance below estimates. UPS reported a fourth-quarter fiscal 2023 revenue decline of 7.8% year-over-year to $24.92 billion, missing the consensus of $25.43 billion. Adjusted EPS was $2.47, down from $3.62 in Q4 2022, in line with the consensus. United Parcel Service shares dipped 8.3% to $145.04 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Agape ATP Corporation (NASDAQ: ATPC) shares jumped 79% to $0.9120. Pixelworks, Inc. (NASDAQ: PXLW) rose 56.8% to $2.3209 after the company entered into a multi-year agreement with Walt Disney Studios. Agrify Corporation (NASDAQ: AGFY) surged 50.7% to $0.9120 after a 13D filing showed I-Tseng Jenny Chan reported a 49.99% stake in the company. Rail Vision Ltd. (NASDAQ: RVSN) gained 38.8% to $20.38 after the company announced its next generation AI-based computer to be incorporated in its Main Line and Switch Yard systems. Inspire Veterinary Partners, Inc. (NASDAQ: IVP) climbed 38% to $0.2359 after falling around 24% on Monday. Inspire Veterinary Partners recently filed a prospectus related to up to a $5 million public offering. Sanmina Corporation (NASDAQ: SANM) shares climbed 36.7% to $69.21 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates. Selina Hospitality PLC (NASDAQ: SLNA) gained 20.8% to $0.4603. C3is Inc. (NASDAQ: CISS) shares surged 19.1% to $0.1609 after a 13G filing showed S.H.N. Financial reported a 9.1% stake in the company. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) rose 18.2% to $0.39. Kura Oncology, Inc. (NASDAQ: KURA) climbed 16.1% to $21.60. Kura Oncology reported preliminary ziftomenib combination data in acute myeloid leukemia. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 13.9% to $1.56 after gaining more than 25% on ...

Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) shares rose sharply in today’s pre-market trading as the company posted upbeat results for its second quarter. Super Micro Computer reported quarterly earnings of $5.59 per share, beating the analyst consensus estimate of $4.93. The company reported quarterly sales of $3.67 billion, which topped the analyst consensus estimate of $3.06 billion. The company also raised its fiscal year 2024 guidance for revenues from a range of $10 billion to $11 billion to a range of $14.3 billion to $14.7 billion. Super Micro Computer shares jumped 10.6% to $548.25 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Agape ATP Corporation (NASDAQ: ATPC) gained 65.1% to $0.8420 in pre-market trading after gaining around 13% on Monday. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 45.3% to $1.99 in pre-market trading after gaining more than 25% on Monday. Petros Pharmaceuticals recently announced completion of initial cohort of Phase 2 equivalent self-selection study. C3is Inc. (NASDAQ: CISS) shares jumped 40.6% to $0.19 in pre-market trading after a 13G filing showed ...

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Urban Outfitters reported quarterly earnings of 88 cents per share, topping the analyst consensus estimate of 82 cents per share. The company reported record quarterly sales of $1.28 billion which exceeded analyst expectations of $1.26 billion, according to data from Benzinga Pro. Urban Outfitters shares fell 9.9% to $32.73 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers AgileThought, Inc. (NASDAQ: AGIL) shares jumped 206.4% to $0.2514 after gaining 5% on Tuesday. PaxMedica, Inc. (NASDAQ: PXMD) rose 33% to $1.08 as the company announced pricing of $7 million public offering. SciSparc Ltd. (NASDAQ: SPRC) gained 29.5% to $8.25 after the company announced it signed a non-binding letter of intent to merge with a vehicle importer company in Israel. Agape ATP Corporation (NASDAQ: ATPC) climbed 22% to $1.15. Agape ATP announced a $1 million share repurchase plan over the next 6 months. Ryvyl Inc. (NASDAQ: RVYL) rose 21.6% to $3.77. The company recently posted a narrower loss for the third quarter. Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares rose 19.3% to $0.2340. HeartSciences recently announced closing ...

Gainers OpGen, Inc. (NASDAQ: OPGN) jumped 593% to $2.33 following two SEC filings from the precision medicine company. The company has received an advanced payment of €750,000 related to the sale of certain Unyvero A50 systems by Curetis to a strategic partner. OpGen also announced a Preferred Stock Purchase Agreement. It signed an agreement with a certain investor to acquire 1,000 shares priced at $1,000 each, with gross proceeds of $1 million. Secoo Holding Limited (NASDAQ: SECO) shares climbed 577.7% to $2.17 after gaining around 12% on Wednesday. Versus Systems Inc. (NASDAQ: VS) shares jumped 305% to $0.8728 after gaining around 7% on Wednesday. Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 90.1% to $0.4601, after gaining over 3% on Wednesday. Atreca, Inc. (NASDAQ: BCEL) gained 87% to $0.4424. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 56.8% to $0.4235. ReShape Lifesciences was granted U.S. patent #11779482 for "Intragrastric Device for Treating Obesity." BSQUARE Corporation (NASDAQ: BSQR) rose 48.4% to $1.84. Kontron America agreed to acquire BSQUARE for $1.90 per share in an all-cash transaction, representing an implied equity value of $38 million. Edesa Biotech, Inc. (NASDAQ: EDSA) gained 37% to $3.70. Edesa Biotech recently announced a one-for-seven reverse share split. LL Flooring Holdings, Inc. (NYSE: LL) jumped 35% to $3.9800. Live Ventures submitted a proposal to acquire LL Flooring for $5.85 per share in cash. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 28.8% to $8.82. Scholar Rock priced upsized $85 million public offering of 12,408,760 common shares at $6.85 per share. LogicMark, Inc. (NASDAQ: LGMK) jumped 27% to $1.9824. Genetron Holdings Limited (NASDAQ: GTH) gained 26% to $1.1994. Genetron Health entered into definitive merger agreement for going private transaction. Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) jumped 24% to $4.65. The company recently announced the successful completion and early discontinuation of the Ibezapolstat Phase 2b trial for the treatment of C. difficile infection. Blue Star Foods Corp. (NASDAQ: BSFC) gained 23% ...

Gainers OpGen, Inc. (NASDAQ: OPGN) shares rose 432% to $1.79 in pre-market trading. Opgen said on Oct. 6, unit Curetis GMBH received payment of 750,000 euros related to the sale of certain Unyvero A50 Systems by Curetis to a strategic partner. Secoo Holding Limited (NASDAQ: SECO) shares gained 465% to $1.81 in pre-market trading after gaining around 12% on Wednesday. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares rose 211% to $0.84 in pre-market trading. ReShape Lifesciences was granted U.S. patent #11779482 for "Intragrastric Device for Treating Obesity." Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 74.2% to $0.4215 in pre-market trading, after gaining over 3% on Wednesday. BSQUARE Corporation (NASDAQ: BSQR) rose 44.4% to $1.79 in pre-market trading. Kontron America agreed to acquire BSQUARE for $1.90 per share in an all-cash transaction, representing an implied equity value of $38 million. Versus Systems Inc. (NASDAQ: VS) shares jumped 43.6% ...